Hrt Financial LP Ngm Biopharmaceuticals Inc Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.6 - $1.31 $7,692 - $16,795	12,821 New	12,821 $11,000
Q2 2023 Aug 11, 2023	SELL	$2.44 - $4.53 $54,814 - $101,766	-22,465 Reduced 17.99%	102,439 $265,000
Q1 2023 May 12, 2023	BUY	$3.72 - $5.4 $464,642 - $674,481	124,904 New	124,904 $509,000
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $1.96 Million - $2.55 Million	-97,313 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $1.47 Million - $2.92 Million	97,313 New	97,313 $1.92 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.